Project Number 1UF1AG046143-01 Agency/Funding Organization NIA Funding Year 2013 View Full Project Details for A PROOF OF CONCEPT STUDY EXAMINING THE SAFETY AND EFFICACY OF INNATE IMMUNE SYSTE Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) a. Amyloid beta Researcher and Organization Principal Investigator ASHBURN, TED T Principal Investigator First Name TED T Principal Investigator Last Name ASHBURN Awardee Organization SANOFI AVENTIS U S, INC. Awardee State New Jersey Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-13-015: ALZHEIMER'S DISEASE PREVENTION TRIALS (R01) FY Overall Cost $2,289,628 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M Related Resources Clinical Trial Safety Study of Sargramostim in Treating Patients With Mild Cognitive Impairment Due to Alzheimer's Disease
